South Africa's PIC draws fire for opposing CFR-Adcock deal; With Mexican stake buy, Richter eyes emerging markets growth;

@FiercePharma: South Africa's top business daily accuses its state pension fund of protectionism vs. a $1.2B deal with Chile's CFR Pharma. More from Reuters | Follow @FiercePharma

@EricPFierce: AstraZeneca gets former Amylin plant & Bristol-Myers Ohio plant in breakup of diabetes venture. Story from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: As GSK hails its FDA nod for Anoro, a Novartis Advair knockoff prepares for its close-up. Story | Follow @CarlyHFierce

> South Africa's top business newspaper lambasted the state-owned Public Investment Corp. for trying to block Chile-based CFR Pharmaceuticals' buyout of the local drugmaker Adcock Ingram. Report

> Hungary-based drugmaker Richter is beefing up in emerging markets again with the $10 million purchase of a 70% stake in Mexico's DNA Pharmaceuticals. Report

> Novartis' ($NVS) generics unit Sandoz launched a Phase III trial for its biosimilar version of AbbVie's ($ABBV) megablockbuster anti-inflammatory drug Humira. Release

> Taking Gilead Sciences' ($GILD) Truvada pill to prevent HIV infection may not encourage high-risk patients to engage in risky sex, a new study found. Release | Report

> Scientists are finding a molecular basis for a potential link between GlaxoSmithKline's ($GSK) pandemic flu vaccine and the sleep disorder narcolepsy. Report

> U.S.-based Perrigo ($PRGO) has wrapped up its buyout of the Irish drug developer Elan. Report

Medical Device News

@FierceMedDev: Investors propel St. Jude Medical to new heights over 2013 rebound. Article | Follow @FierceMedDev

@MarkHFierce: So, how many device companies will go for FDA/CMS parallel review now that the pilot program has been extended? More | Follow @MarkHFierce

@MichaelGFierce: Synapse collects state-funded $2.4M for next-gen diaphragm pacing device. Item | Follow @MichaelGFierce

@GalenMoore: ICYMI: Despite tax hike, Medtronic's money still flies to Puerto Rico. Story | Follow @GalenMoore

> Decision Diagnostics is raising cash to keep its J&J glucose strip patent fight running. More

Biotech News

@FierceBiotech: Alimera, pSivida skyrocket as they give the thrice-rejected Iluvien another go. More | Follow @FierceBiotech

@JohnCFierce: Another day, another positive PhIII study for AMG 145 (PCSK9). Release | Follow @JohnCFierce

@DamianFierce: GSK and Theravance score another FDA approval with Anoro, a novel COPD combo therapy. News | Follow @DamianFierce

@EmilyMFierce: BRAIN Initiative announces 6 funding opportunities for biomedical researchers. More from FierceBiotech Research | Follow @EmilyMFierce

> Alimera, pSivida skyrocket as they give the thrice-rejected Iluvien another go. Article

> Vertex's Kalydeco flunks a Phase III for cystic fibrosis. Story

> AstraZeneca will pay up to $4.1B for Bristol's share of their diabetes pact. More

> Bayer bags Algeta's cancer drug portfolio for $2.9B. News

Pharma Manufacturing News

> Hacked off: Congress members, PhRMA urge an outside audit of the FDA data breach. Story

> Regeneron will invest $300M, hire 300 in its revamp of a Dell plant in Ireland. More

> The FDA and EU members will share some inspection duties. News

> AstraZeneca will take over 2 U.S. plants in its $4.1B diabetes drug transfer. Report

> CEO Nakayama says Daiichi Sankyo is helping Ranbaxy deal with the FDA's concerns. Article

> FDA puts veterinary drugs from banned Wockhardt plants on a leash. Item

Vaccines News

> Schulman leaves Pfizer weeks before start date of new top vaccine job. More

> CDC: Vaccines prevented 6M cases of flu, 79,000 hospitalizations last year. News

> Moderate alcohol consumption acts as vaccine adjuvant in monkeys. Article

> Physician failings raise doubts about the potency of U.K. vaccines. Story

> Agenus stock jumps on Phase II brain cancer vaccine data. Piece

> California calls for unapproved Bexsero to stop its meningitis outbreak. Item

And Finally... About half of the raw chicken breasts in a U.S. sampling carried antibiotic-resistant "superbug" bacteria. Report

Suggested Articles

Creating a relevant online health user experience has its payoffs — for both the user and the brand. Here’s why.

Sanofi's new strategy delivered for the drugmaker in the third quarter as Dupixent posted blockbuster sales and flu vaccines set a revenue record.

Catalent has acquired Bone Therapeutics' cell and gene therapy site in Gosselies, Belgium, to add to its growing "center of excellence" there.